{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:41:31Z","timestamp":1771623691737,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"DOI":"10.7759\/cureus.100829","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:15:37Z","timestamp":1767622537000},"source":"Crossref","is-referenced-by-count":1,"title":["Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema Presenting After Long-Term Antihypertensive Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Mohammed","family":"Khalid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifa","family":"Nafis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02596-4","article-title":"Vasopeptidase inhibition and angio-oedema","volume":"356","author":"Messerli FH","year":"2000","unstructured":"Messerli FH, Nussberger J. Vasopeptidase inhibition and angio-oedema. Lancet. 2000, 356:608-9. 10.1016\/S0140-6736(00)02596-4","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D458","article-title":"Intermittent visceral edema induced by long-term enalapril administration","volume":"38","author":"Orr KK","year":"2004","unstructured":"Orr KK, Myers JR. Intermittent visceral edema induced by long-term enalapril administration. Ann Pharmacother. 2004, 38:825-7. 10.1345\/aph.1D458","journal-title":"Ann Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-011-0238-z","article-title":"ACE inhibitor-induced angioedema","volume":"12","author":"Vasekar M","year":"2012","unstructured":"Vasekar M, Craig TJ. ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep. 2012, 12:72-8. 10.1007\/s11882-011-0238-z","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.130.12.1416","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists","volume":"130","author":"Kyrmizakis DE","year":"2004","unstructured":"Kyrmizakis DE, Papadakis CE, Liolios AD, et al.. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists. Arch Otolaryngol Head Neck Surg. 2004, 130:1416-9. 10.1001\/archotol.130.12.1416","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2003.00484.x","article-title":"An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors","volume":"10","author":"Morimoto T","year":"2004","unstructured":"Morimoto T, Gandhi TK, Fiskio JM, et al.. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract. 2004, 10:499-509. 10.1111\/j.1365-2753.2003.00484.x","journal-title":"J Eval Clin Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12341","article-title":"A consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman JJ","year":"2014","unstructured":"Moellman JJ, Bernstein JA, Lindsell C, et al.. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014, 21:469-84. 10.1111\/acem.12341","journal-title":"Acad Emerg Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/all.13384","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014the 2017 revision and update","volume":"73","author":"Maurer M","year":"2018","unstructured":"Maurer M, Magerl M, Ansotegui I, et al.. The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014the 2017 revision and update. Allergy. 2018, 73:1575-96. 10.1111\/all.13384","journal-title":"Allergy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-6-19","article-title":"Management of upper airway edema caused by hereditary angioedema","volume":"6","author":"Farkas H","year":"2010","unstructured":"Farkas H. Management of upper airway edema caused by hereditary angioedema. Allergy Asthma Clin Immunol. 2010, 6:19. 10.1186\/1710-1492-6-19","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/448955-angiotensin-converting-enzyme-ace-inhibitor-induced-angioedema-presenting-after-long-term-antihypertensive-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:15:37Z","timestamp":1767622537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/448955-angiotensin-converting-enzyme-ace-inhibitor-induced-angioedema-presenting-after-long-term-antihypertensive-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.100829","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,5]]}}}